Effect H2 Water on QoL of Patients Receiving Radiotherapy for High Grade Gliomas. (NCT04175301)

🧪 Interventions in This Study

• Hydrogen (DRUG)
• Placebo oral tablet (DRUG)

Full eligibility criteria are available on the official NIH protocol. View the criteria ↗

📍 All Participating Trial Locations (1 Sites)

• Stony Brook University Medical Center — Stony Brook, New York

💰 Cost, Insurance & Patient Rights

• 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
• Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
• Voluntary Participation: You may withdraw at any time without affecting your standard medical care.

More studies in Malignant Glioma

• A Pilot Study Using 18F-DOPA PET-guided Radiotherapy in Gliomas — Rochester, Minnesota
• Fitness and Nutrition in Glioma — New York, New York
• Optune for Children With High-Grade Glioma or Ependymoma, and Optune With Radiation Therapy for Children With DIPG — Phoenix, Arizona
• D2C7-IT With Atezolizumab for Recurrent Gliomas — Durham, North Carolina
• Serial Advanced Magnetic Resonance Imaging Scan for Guidance of Personalized Adaptive Radiotherapy for High Grade Glioma — Houston, Texas

Explore by condition: All Malignant Glioma clinical trials

💡 How to Participate

1. Check the checklist above to see if you may qualify.
2. Review the official NIH record below to find the coordinating site.
3. Ask about the visit schedule, what is covered at no cost, and any travel support.
4. Confirm with your own doctor before making a decision.